Community-acquired bacterial meningitis in Southern Sweden 2013-2023: a population-based study of incidence,

Tobias West1,2, Robin Carlander3, Torgny Sunnerhagen3,4

  • 1Division of Infection Medicine, Department of Clinical Sciences, Faculty of Medicine, Lund University, Lund, Sweden. tobias.west@med.lu.se.

Abstract

Insights

Community-acquired bacterial meningitis (CABM) incidence is declining in southern Sweden, primarily driven by Streptococcus pneumoniae. Vaccination strategies are crucial for further reducing CABM and addressing serotype distribution.

Area of Science:

  • Infectious Diseases
  • Epidemiology
  • Vaccinology

Background:

  • Bacterial meningitis remains a global health concern, with incidence and causes influenced by demographics and vaccination.
  • Understanding current trends in community-acquired bacterial meningitis (CABM) is essential for public health strategies.

Purpose of the Study:

  • To determine the incidence and etiology of CABM in southern Sweden from 2013-2023.
  • To analyze the serotypes of Streptococcus pneumoniae and Neisseria meningitidis causing CABM in relation to vaccine availability.

Main Methods:

  • Retrospective study of all-age CABM patients in southern Sweden (2013-2023).
  • Patient identification via cerebrospinal fluid test records and ICD-10 codes.
  • Calculation of age-standardized incidence rates using the European Standard Population 2013.

Main Results:

  • 244 CABM episodes identified; definitive etiology in 93%.
  • Mean incidence rate of 1.63 per 100,000 person-years, showing a declining trend.
  • Streptococcus pneumoniae was the most frequent pathogen (46.7%), with 63.6% of cases caused by vaccine-included serotypes.

Conclusions:

  • Pneumococcal meningitis is the main driver of CABM incidence and trends in southern Sweden.
  • Further research is needed on vaccination's impact on CABM incidence and serotype shifts.
  • Identifying optimal patient groups for targeted interventions is crucial.

Related Concept Videos

Investigation of Disease Outbreaks01:23

Investigation of Disease Outbreaks

Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...